RxDoctor Payments Data

Rose Soto, NP

Adult Health · Syracuse, NYNPI 1376591099

Payments from drug & device makers

$12,221in general payments, 2019–2025

Across 570 payments — averaging $21.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Abbott$2K
  • Biogen$688
  • UCB, Inc.$657
  • Pfizer$611
  • EMD Serono, Inc.$579
  • plus $6K from 50 others

What the payments were for

  • Travel & lodging$1,0529%
  • Food & beverage$10,77588%
  • Education$3933%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie155$1,867
Abbott17$1,650
Biogen35$688
UCB, Inc.19$657
Pfizer57$611
EMD Serono, Inc.14$579
AstraZeneca12$388
Lilly USA, LLC19$363
Neurocrine Biosciences, Inc.18$348
Novartis13$310
Lundbeck LLC12$269
Kyowa Kirin, Inc.12$264
Genentech USA, Inc.13$248
Sanofi10$234
Amneal Pharmaceuticals LLC10$220
TG Therapeutics, Inc.8$210
Argenx US, Inc.7$202
Teva Pharmaceuticals USA, Inc.5$193
Eisai Inc.7$192
Averitas Pharma Inc.3$169
Johnson & Johnson6$166
Otsuka America Pharmaceutical, Inc.8$162
Amgen(2 entities)7$162
Acadia Pharmaceuticals Inc10$152
Mylan Specialty L.p.3$137
Biohaven Pharmaceuticals, Inc.10$136
Biohaven Pharmaceutical Holding Company Ltd.11$129
Bristol Myers Squibb6$123
Medtronic4$112
Jazz Pharmaceuticals Inc.4$112
Sumitomo Pharma America, Inc.9$103
MDD US Operations, LLC3$95
Mallinckrodt Hospital Products Inc.3$83
Merz Pharmaceuticals, LLC3$69
Supernus Pharmaceuticals, Inc.2$68
Impel Pharmaceuticals LLC3$67
Axsome Therapeutics, Inc.2$61
Takeda Pharmaceuticals U.S.A., Inc.2$57
SK Life Science, Inc.2$57
Tanabe Pharma America, Inc.2$53
ANI Pharmaceuticals, Inc.2$49
Novo Nordisk2$42
Neurelis, Inc.1$40
Catalyst Pharmaceuticals, Inc.1$40
Sunovion Pharmaceuticals Inc.6$38
Vanda Pharmaceuticals Inc.1$34
Impel Pharmaceuticals Inc.1$31
Avion Pharmaceuticals2$25
Xeris Pharmaceuticals, Inc.1$25
Banner Life Sciences, LLC1$24
Scilex Pharmaceuticals Inc.1$23
Alnylam Pharmaceuticals Inc.1$22
Acorda Therapeutics, Inc1$18
Avadel CNS Pharmaceuticals, LLC1$15
Collegium Pharmaceutical, Inc.1$14
Arbor Pharmaceuticals, Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,221 in reported general payments places this provider in the 95th percentile of 3,828 adult health providers in New York.

See all adult health providers in New York

Medicare billing

Part B allowed, 2024
$28,329
Medicare patients
189
Services billed
401

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Teriflunomide17$104,266
NuplazidPimavanserin Tartrate15$95,377
CopaxoneGlatiramer Acetate13$74,300
Nurtec OdtRimegepant Sulfate24$29,776
Glatiramer Acetate13$23,552
Dalfampridine ErDalfampridine19$16,936
Emgality PenGalcanezumab-Gnlm19$16,110
VimpatLacosamide14$15,792
Lamotrigine ErLamotrigine31$11,295
Ajovy SyringeFremanezumab-Vfrm11$11,163
Rivastigmine24$6,106
Baclofen97$5,261
Entacapone25$5,243
Gabapentin237$4,335
Divalproex Sodium38$3,673

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Acadia Pharmaceuticals IncNuplazid$152$95,37715 claims
Teva Pharmaceuticals USA, Inc.Copaxone$193$74,30013 claims
PfizerNurtec Odt$611$29,77624 claims
UCB, Inc.Vimpat$657$15,79214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,828 adult health providers in New York.

Other adult health in Syracuse

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →